Login
← Go Back
Windlas Biotech
WINDLAS · Pharma > Pharmaceuticals & Drugs · Chairman: Vivek Dhariwal · MD: Hitesh Windlass · Listing date: Aug. 17, 2021 · Employees: 1028 · Gurugram · http://windlasbiotech.com
Stock Price vs Company Growth
1d
1.9%
1w
2.8%
1m
8.5%
3m
15.8%
6m
17.2%
1y
13.8%
5y
19.8%
all
18.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 917 1.9%
749
993
Company Overview
Sales
904 Cr
Growth: 17.9%
Profit after Tax
66.5 Cr
Growth: -0.4%
Small Cap
1,892 Cr
P/E: 29.3x
Industry P/E: 31.7x
Fundamentals
Sales (Cr) ₹ 904
Growth 17.9%
EBITDA 11.6%
P/S 2.1x
Dividend 0.6%
P/E 29.3x
Book Value ₹ 281
PEG Ratio 1.7x
ROE 12.1%
P/B 3.3x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. Awards, accreditations and recognitions2018: The company was awarded the TV100 Industrial Excellence Award in the field of medicine.
Belongs to (4 Indices)
Investors (3)
jainam.b...
ajay.kum...
ravi036
Followers (2)
kotekar
varsha96